D Tomek
Impact in
-
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Healthcare Policy and Management
- Economic and Financial Impacts of Cancer
-
- Global Health Care Issues
- Healthcare cost, quality, practices
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Pharmaceutical Economics and Policy 4
- Economic and Financial Impacts of Cancer 1
- Healthcare Policy and Management 1
-
- Systemic Sclerosis and Related Diseases 1
- Co-authors
- Jan Mužı́k (1 shared paper)Mark Nuijten (1 shared paper)Karel Němeček (1 shared paper)Ľuba Hunáková (1 shared paper)D Ondruš (1 shared paper)Emese Kiss (1 shared paper)Maciej Niewada (1 shared paper)Martina Ondrušová (1 shared paper)
- Journals
- Value in Health (7 papers)Clinical & Translational Oncology (1 paper)Frontiers in Pharmacology (1 paper)Value in Health Regional Issues (1 paper)The European Journal of Health Economics (1 paper)
- Partner nations
- SlovakiaCzechiaUnited States
In The Last Decade
D Tomek
9 papers receiving 37 citations
Peers
Comparison fields: 5 of 29
- Economics and Econometrics 22
- General Health Professions 9
- Emergency Medical Services 2
- Internal Medicine 1
- Geriatrics and Gerontology 1
Countries citing papers authored by D Tomek
This map shows the geographic impact of D Tomek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Tomek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Tomek more than expected).
Fields of papers citing papers by D Tomek
This network shows the impact of papers produced by D Tomek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Tomek. The network helps show where D Tomek may publish in the future.
Co-authors
The 13 scholars most cited alongside D Tomek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 11 | |
| 2 | 2017 | 8 | |
| 3 | 2020 | 7 | |
| 4 | 2012 | 6 | |
| 5 | 2014 | 1 | |
| 6 | 2011 | 1 | |
| 7 | 2011 | 1 | |
| 8 | 2015 | 1 | |
| 9 | 2014 | 1 | |
| 10 | 2013 | 0 | |
| 11 | 2014 | 0 |
About D Tomek
D Tomek is a scholar working on Economics and Econometrics, Pathology and Forensic Medicine, Reproductive Medicine, General Health Professions and Oncology, having authored 11 papers that have together received 37 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Pharmaceutical Economics and Policy (4 papers), Endometriosis Research and Treatment (2 papers), Rheumatoid Arthritis Research and Therapies (1 paper), Systemic Sclerosis and Related Diseases (1 paper), Economic and Financial Impacts of Cancer (1 paper), Healthcare Policy and Management (1 paper) and Systemic Lupus Erythematosus Research (1 paper). The work is most often cited by research in Economics and Econometrics (22 citations), General Health Professions (9 citations), Emergency Medical Services (2 citations), Internal Medicine (1 citation) and Geriatrics and Gerontology (1 citation). D Tomek has collaborated with scholars based in Slovakia, Czechia and United States. Frequent co-authors include Jan Mužı́k, Mark Nuijten, Karel Němeček, Ľuba Hunáková, D Ondruš, Emese Kiss, Maciej Niewada, Martina Ondrušová, László Lorenzovici and Zoltán Kaló. Their work appears in journals such as Value in Health, Clinical & Translational Oncology, Frontiers in Pharmacology, Value in Health Regional Issues and The European Journal of Health Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.